Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 5:12 pm Purchase |
2020-12-31 | 13G | Genocea Biosciences, Inc. GNCA |
GSK PLC | 5,217,389 9.900% |
1,540,622 (+41.90%) |
Filing History |
| 2021-02-12 5:10 pm Sale |
2020-12-31 | 13G | Progyny, Inc. PGNY |
GSK PLC | 2,926,957 3.400% |
-7,600,000 (-72.20%) |
Filing History |
| 2021-01-29 09:54 am Purchase |
2020-12-31 | 13G | GSK plc GSK |
BlackRock Inc. BLK |
301,827,410 7.500% |
900,022 (+0.30%) |
Filing |
| 2020-12-07 5:08 pm Sale |
2020-11-05 | 13D | Spero Therapeutics, Inc. SPRO |
GSK PLC | 1,740,606 6.400% |
-78,872 (-4.33%) |
Filing History |
| 2020-12-07 5:06 pm Sale |
2020-11-05 | 13D | Bicycle Therapeutics plc BCYC |
GSK PLC | 1,894,831 8.900% |
-20,444 (-1.07%) |
Filing History |
| 2020-11-30 5:05 pm Purchase |
2020-11-20 | 13G | F-star Therapeutics, Inc. FSTX |
GSK PLC | 803,922 8.900% |
803,922 (New Position) |
Filing History |
| 2020-11-06 5:26 pm Purchase |
2020-10-29 | 13D | Turning Point Therapeutics, Inc. TPTX |
GSK PLC | 2,273,618 4.900% |
4,958 (+0.22%) |
Filing History |
| 2020-09-30 9:00 pm Unchanged |
2020-09-28 | 13D | Morphic Holding, Inc. MORF |
GSK PLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2020-08-24 4:12 pm Purchase |
2020-08-13 | 13G | CureVac N.V. CVAC |
GSK PLC | 14,935,721 8.400% |
14,935,721 (New Position) |
Filing History |
| 2020-07-31 5:39 pm Purchase |
2020-07-21 | 13D | PANDION THERAPEUTICS INC PAND |
GSK PLC | 2,262,301 7.900% |
2,262,301 (New Position) |
Filing History |
| 2020-07-22 5:23 pm Purchase |
2020-07-14 | 13D | Nkarta, Inc. NKTX |
GSK PLC | 3,161,432 9.700% |
3,161,432 (New Position) |
Filing History |
| 2020-07-10 5:26 pm Purchase |
2020-07-06 | 13D | CRISPR Therapeutics AG CRSP |
GSK PLC | 3,310,627 4.800% |
15,000 (+0.46%) |
Filing History |
| 2020-06-29 6:17 pm Sale |
2020-06-23 | 13D | Morphic Holding, Inc. MORF |
GSK PLC | 1,431,551 4.700% |
-102,221 (-6.66%) |
Filing History |
| 2020-06-22 5:13 pm Unchanged |
2020-06-22 | 13D | Theravance Biopharma, Inc. TBPH |
GSK PLC | 9,644,807 15.300% |
0 (Unchanged) |
Filing History |
| 2020-06-17 4:07 pm Sale |
2020-06-17 | 13D | Theravance Biopharma, Inc. TBPH |
GSK PLC | 9,644,807 15.300% |
-1 (-0.00%) |
Filing History |
| 2020-06-04 5:03 pm Sale |
2020-06-01 | 13D | Spero Therapeutics, Inc. SPRO |
GSK PLC | 1,819,478 8.800% |
-114,528 (-5.92%) |
Filing History |
| 2020-05-26 5:06 pm Purchase |
2020-05-21 | 13D | Turning Point Therapeutics, Inc. TPTX |
GSK PLC | 2,268,660 5.500% |
276,110 (+13.86%) |
Filing History |
| 2020-05-04 4:18 pm Purchase |
2020-04-22 | 13G | Vir Biotechnology, Inc. VIR |
GSK PLC | 6,626,027 6.030% |
6,626,027 (New Position) |
Filing History |